Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Pilot Study of Nucleo CMP Forte in Median Nerve Compression Neuropathy (Carpal Tunnel Syndrome)
2014-003272-23Phase 4Active
- Sponsor
- Dr. Jordi Montero Homs
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Nucleo CMP Forte in carpal tunnel syndrome (CTS), sponsored by Dr. Jordi Montero Homs. Primary endpoints: Pain intensity at 6 months of treatment and Pain intensity 30 days after last dose. Started Sep 2014; status: active.
02
Drugs
Nucleo CMP Forte
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on 2014-003272-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003272-23.